INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT
The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process: Formula (I) wherein R1, R2, R3, R4, R6
-
(2021/12/28)
COMPOUNDS
Provided are benzoxazolinone sulfonamide derivatives that inhibit Na v1.7 activity, pharmaceutical compositions containing them and their use in therapy for the treatment of diseases mediated by Na v1.7 activity.
-
Page/Page column 62; 63
(2018/12/03)
More Articles about upstream products of 1049677-40-8